Response of limbic neurotensin systems to methamphetamine self-administration

Neuroscience

Volumn 203, Issue , 2012, Pages 99-107

  Hanson, G R ^a   Hoonakker, A J ^a   Alburges, M E ^a   McFadden, L M ^a   Robson, C M ^a   Frankel, P S ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

Dopamine; Dorsal striatum; Methamphetamine; Neurotensin; Nucleus accumbens; Self administration

Indexed keywords

METHAMPHETAMINE; NEUROPEPTIDE; NEUROTENSIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; BRAIN REGION; BRAIN TISSUE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG SELF ADMINISTRATION; LIMBIC SYSTEM; MALE; MOTOR ACTIVITY; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; STIMULUS RESPONSE; VENTRAL TEGMENTUM;

ANIMALS; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM STIMULANTS; CORPUS STRIATUM; DOPAMINE; MALE; METHAMPHETAMINE; NEUROTENSIN; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; SELF ADMINISTRATION;

EID: 84856481314     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.12.037     Document Type: Article

References (36)

1. Adams D.H., Hanson G.R., Keefe K.A. Differential effects of cocaine and methamphetamine on neurotensin/neuromedin N and preprotachykinin messenger RNA expression in unique regions of the striatum. Neuroscience 2001, 102:843-851.
2. Alburges M.E., Hanson G.R. Differential responses by neurotensin systems in extrapyramidal and limbic structures to ibogaine and cocaine. Brain Res 1999, 818:96-104.
3. Alburges M.E., Hoonakker A.J., Horner K.A., Fleckenstein A.E., Hanson G.R. Methylphenidate alters basal ganglia neurotensin systems through dopaminergic mechanisms: a comparison with cocaine treatment. J Neurochem 2011, 117:470-478.
4. Antonelli T., Tomasini M.C., Fuxe K., Agnati L.F., Tanganelli S., Ferraro L. Receptor-receptor interactions as studied with microdialysis. Focus on NTR/D2 interactions in the basal ganglia. J Neural Transm 2007, 114:105-113. [Review].
5. Azzi M., Betancur C., Sillaber I., Spanagel R., Rostène W., Bérod A. Repeated administration of the neurotensin receptor antagonist SR 48692 differentially regulates mesocortical and mesolimbic dopaminergic systems. J Neurochem 1998, 71:1158-1167.
6. Boules M., Oliveros A., Liang Y., Williams K., Shaw A., Robinson J., Fredrickson P., Richelson E. A neurotensin analog, NT69L, attenuates intravenous nicotine self-administration in rats. Neuropeptides 2011, 45:9-16.
7. Carlezon W.A., Thomas M.J. Biological substrates of reward and aversion: a nucleus accumbens activity hypothesis. Neuropharmacology 2009, 56(Suppl 1):122-132.
8. Castel M.N., Morino P., Dagerlind A., Hokfelt T. Up-regulation of neurotensin mRNA in the rat sriatum after acute methamphetamine treatment. Eur J Neurosci 1994, 6:646-656.
9. Castel M.N., Morino P., Nylander I., Terenius L., Hofkelt T. Differential dopaminergic regulation of the neurotensin striatonigral and striatopallidal pathways in the rat. Eur J Pharmacol 1994, 262:1-10.
10. Chartoff E.H., Szczypka M.S., Palmiter R.D., Dorsa D.M. Endogenous neurotensin attenuates dopamine-dependent locomotion and stereotypy. Brain Res 2004, 1022:71-80.
11. Elkashef A., Vocci F., Hanson G., White J., Wickes W., Tiihonen J. Pharmacotherapy of methamphetamine addiction: an update. Subst Abus 2008, 29:31-49.
12. Feifel D., Melendez G., Murray R., Tina Tran D., Rullan M., Shilling P. The reversal of amphetamine-induced activation by a selective neurotensin-1 receptor agonist does not exhibit tolerance. Psychopharmacology (Berl) 2008, 200:197-203.
13. Ferraro L., Antonelli T., O'Connor W.T., Fuxe K., Soubrié P., Tanganelli S. The striatal neurotensin receptor modulates striatal and pallidal glutamate and GABA release: functional evidence for a pallidal glutamate-GABA interaction via the pallidal-subthalamic nucleus loop. J Neurosci 1998, 18:6977-6989.
14. Ferraro L., Tomasini M.C., Fuxe K., Agnati L.F., Mazza R., Tanganelli S., Antonelli T. Mesolimbic dopamine and cortico-accumbens glutamate afferents as major targets for the regulation of the ventral striato-pallidal GABA pathways by neurotensin peptides. Brain Res 2007, 55:144-154.
15. Fleckenstein A.E., Volz T.J., Riddle E.L., Gibb J.W., Hanson G.R. New insights into the mechanism of action of amphetamines. Annu Rev Pharmacol Toxicol 2007, 47:681-698.
16. Frankel P.S., Alburges M.E., Bush L., Hanson G.R., Kish S. Brain levels of neuropeptides in human chronic methamphetamine abusers. Neuropharmacology 2007, 5:447-454.
17. Frankel P.S., Hoonakker A.J., Alburges M.E., McDougall J.W., McFadden L.M., Fleckenstein A.E., Hanson G.R. Effect of methamphetamine self-administration on neurotensin systems of the basal ganglia. J Pharmacol Exp Ther 2011, 336:809-815.
18. Fuchs R.A., Evans K.A., Ledford C.C., Parker M.P., Case J.M., Mehta R.H., See R.E. The role of the dorsomedial prefrontal cortex, basolateral amygdala, and dorsal hippocampus in contextual reinstatement of cocaine seeking in rats. Neuropsychopharmacology 2005, 30:296-309.
19. Geisler S., Zahm D.S. Neurotensin afferents of the ventral tegmental area in the rat: [1] re-examination of their origins and [2] response to acute psychostimulant and antipsychotic drug administration. Eur J Neurosci 2006, 24:116-134.
20. Hadden M.K., Orwig K.S., Kokko K.P., Mazella J., Dix T.A. Design, synthesis, and evaluation of the antipsychotic potential of orally bioavailable neurotensin (8-13) analogues containing non-natural arginine and lysine residues. Neuropharmacology 2005, 49:1149-1159.
21. Hanson G.R., Singh N., Merchant K., Johnson M., Bush L., Gibb J.W. Responses of limbic and extrapyramidal neurotensin systems to stimulants of abuse. Involvement of dopaminergic mechanisms. Ann N Y Acad Sci 1992, 668:165-172.
22. Hanson G.R., Singh N., Merchant K., Johnson M., Gibb J.W. The role of NMDA receptor systems in neuropeptide responses to stimulants of abuse. Drug Alcohol Depend 1995, 37:107-110.
23. Merchant K.M., Letter A.A., Gibb J.W., Hanson G.R. Changes in the limbic neurotensin systems induced by dopaminergic drugs. Eur J Pharmacol 1988, 153:1-9.
24. Merchant K.M., Gibb J.W., Hanson G.R. Role of dopamine D-1 and D-2 receptors in the regulation of neurotensin systems of the neostriatum and the nucleus accumbens. Eur J Pharmacol 1989, 160:409-412.
25. Merchant K.M., Hanson G.R., Dorsa D.M. Induction of neurotensin and c-fos mRNA in distinct subregions of rat neostriatum after acute methamphetamine: comparison with acute haloperidol effects. J Pharmacol Exp Ther 1994, 269:806-812.
26. Meredith C.W., Jaffe C., Ang-Lee K., Saxon A.J. Implications of chronic methamphetamine use: a literature review. Harv Rev Psychiatry 2005, 13:141-154.
27. Paxinos P., Watson C. The rat brain in stereotaxic coordinates 1982, Academic Press, San Diego.
28. Petrie K.A., Bubser M., Casey C.D., Davis M.D., Roth B.L., Deutch A.Y. The neurotensin agonist PD149163 increases Fos expression in the prefrontal cortex of the rat. Neuropsychopharmacology 2004, 29:1878-1888.
29. Ramos-Ortolaza D.L., Negrón A., Cruz D., Falcón E., Iturbe M.C., Cajigas M.H., Maldonado-Vlaar C.S. Intra-accumbens shell injections of SR48692 enhanced cocaine self-administration intake in rats exposed to an environmentally-elicited reinstatement paradigm. Brain Res 2009, 1280:124-136.
30. Robledo P., Maldonado R., Koob G.F. Neurotensin injected into the nucleus accumbens blocks the psychostimulant effects of cocaine but does not attenuate cocaine self-administration in the rat. Brain Res 1993, 622:105-112.
31. Schwendt M., Rocha A., See R.E., Pacchioni A.M., McGinty J.F., Kalivas P.W. Extended methamphetamine self-administration in rats results in a selective reduction of dopamine transporter levels in the prefrontal cortex and dorsal striatum not accompanied by marked monoaminergic depletion. J Pharmacol Exp Ther 2009, 331:555-562.
32. See R.E., Elliott J., Feltenstein M. The role of dorsal vs ventral striatal pathways in cocaine-seeking behavior after prolonged abstinence in rats. Psychopharmacology (Berl) 2007, 194:321-331.
33. Singh N.A., Bush L.G., Gibb J.W., Hanson G.R. Role of N-methyl-d-aspartate receptors in dopamine D1-, but not D2-, mediated changes in striatal and accumbens neurotensin systems. Brain Res 1992, 571:260-264.
34. Torregrossa M.M., Kalivas P.W. Neurotensin in the ventral pallidum increases extracellular gamma-aminobutyric acid and differentially affects cue- and cocaine-primed reinstatement. J Pharmacol Exp Ther 2008, 325:556-566.
35. Wagstaff J., Gibb J.W., Hanson G.R. Microdialysis of methamphetamine-induced changes in extracellular neurotensin in the striatum and nucleus accumbens. J Pharmacol Exp Ther 1996, 27:547-554.
36. Wagstaff J.D., Bush L.G., Gibb J.W., Hanson G.R. Endogenous neurotensin antagonizes methamphetamine-enhanced dopaminergic activity. Brain Res 1994, 665:237-244.